Stanford University · Biomedical EngineeringCancer Imaging and Biomarkers Lab
Ruijiang Li · Stanford, California
Research Focus
Dr. Ruijiang Li's lab focuses on developing advanced imaging techniques and blood-based biomarkers to personalize cancer treatments, particularly for lung, oropharyngeal, gastric, and rectal cancers. The research aims to enhance prediction of patient responses to immunotherapy and other treatments, which could ultimately improve outcomes and help tailor therapies to individual patients' needs.
personalized medicinecancer immunotherapybiomarkersimaging techniquesradiomicsdeep learninglung canceroropharyngeal cancergastric cancer
Research Aims
5AIM 01Develop noninvasive imaging and blood biomarkers for lung cancer immunotherapy.
AIM 02Create predictive models for treatment response in oropharyngeal cancer.
AIM 03Establish robust imaging features for personalized gastric cancer treatment.
AIM 04Integrate imaging data with clinical data for better risk stratification.
AIM 05Investigate MRI biomarkers for treatment outcomes in rectal cancer.
Skills the Lab Values
MRICT imagingdeep learningblood biomarker analysisradiomicsdata integrationimage processingclinical trial designmachine learning
Output against the department
Publications291top 32% of dept.190th of 595
this lab
most publishedleast published
Citations8.6ktop 39% of dept.234th of 595
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.